Among these molecules, Salternamide A inhibited the hypoxia-induced accumulation of HIF-1α in several cancer cell lines and suppressed the HIF-1α by downregulation of its upstream signaling pathways such as PI3K/Akt/mTOR, p42/p44 MAPK, and STAT3. The gene discussed is HIF1A; the disease is cancer.